Table 2. Clinical and epidemiologic characteristics for 6 Bordetella holmesii–infected patients during pertussis outbreak, Japan, September 2010–April 2011*.
Patient no. | Whoop | Duration of cough | Treatment | DTP vaccine status, no. doses | Medical history | Epidemiologic findings |
---|---|---|---|---|---|---|
1 | + | 10 d | AZM | 4 | Asthma | Student at high school A. His 14-year-old sister, who was given a diagnosis of pertussis, was a student at junior high school B. |
2 | + | 28 d | AZM | 4 | −– | Student at junior high school B. Her 18-year-old brother had similar symptoms, but laboratory test results were negative. |
3 | – | >4 wk | AZM | 4 | – | Student at junior high school B. Her close friends began coughing after her disease onset. |
4 | + | 15 d | AZM | 4 | Chlamydial pneumonia | Student at junior high school B. Her 11-year-old sister was given a diagnosis of pertussis before her disease onset. |
5 | −– | 28 d | AZM | UNK | Allergic rhinitis | Teacher at junior high school B in charge of patient 4. |
6 | – | 23 d | AZM, CFPN-PI, GRNX | UNK | Rheumatoid arthritis | Medical staff at clinic C, which was visited by patients 1–5. |
*All patients had a paroxysmal cough and coughed at night; none had posttussive vomiting. DTP, diphtheria-tetanus-pertussis; +, positive; AZM, azithromycin; –, negative; UNK, unknown; CFPN-PI, cefcapene pivoxil; GRNX, garenoxacin.